Literature DB >> 20078409

The rational clinician in a pandemic setting.

David A Bradt1, Joseph Epstein.   

Abstract

Pandemic (H1N1) 2009 influenza has generated many controversies in Australia around case definitions, laboratory diagnosis, case management, medical logistics and travel restrictions. Our experience as clinical advisers in the Victorian Department of Human Services Emergency Operations Centre suggests the following: Case definitions may change frequently, and will tend to become more clinically specific over time. Early in a pandemic, laboratory diagnosis plays a critical role in case finding and pathogen identification. Later in the pandemic, standardised case management applied to well crafted case definitions should reduce reliance on the diagnostic laboratory in clinical management. The diagnostic laboratory will remain critical to monitoring disease surveillance, pathogen virulence, and drug susceptibility. Medical logistics will continue to challenge pandemic managers as the health sector struggles to do the most good for the greatest number of people. Travel restrictions remain scientifically controversial public health recommendations. Issues of scalability (escalation and de-escalation of the response) relating to virus lethality need to be resolved in current pandemic planning.

Entities:  

Mesh:

Year:  2010        PMID: 20078409

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  2 in total

1.  Determination of the relative economic impact of different molecular-based laboratory algorithms for respiratory viral pathogen detection, including Pandemic (H1N1), using a secure web based platform.

Authors:  Bonita E Lee; Shamir N Mukhi; Jennifer May-Hadford; Sabrina Plitt; Marie Louie; Steven J Drews
Journal:  Virol J       Date:  2011-06-06       Impact factor: 4.099

2.  Diagnosing swine flu: the inaccuracy of case definitions during the 2009 pandemic, an attempt at refinement, and the implications for future planning.

Authors:  Andrew A Mahony; Allen C Cheng; Karen L Olsen; Craig A Aboltins; James F P Black; Paul D R Johnson; M Lindsay Grayson; Joseph Torresi
Journal:  Influenza Other Respir Viruses       Date:  2012-06-19       Impact factor: 4.380

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.